Expanded AIDS research consortium

A national AIDS research consortium led by the University of Alabama at Birmingham (UAB) has two new university partners.

The Centers for AIDS Research at Vanderbilt University in Nashville, Tenn. and at the University of North Carolina at Chapel Hill are now part of the nine-member consortium run by UAB's Center for AIDS Research (CFAR).

The consortium is called CFAR Network of Integrated Clinical Systems (CNICS).

"Adding the Vanderbilt and North Carolina centers deepens the network's expertise and adds to our ever growing database of AIDS testing and research results," said Michael Saag, M.D., director of UAB's CFAR. "We've started a new paradigm for clinical investigation - a way to combine, expedite and improve real-time population-based studies vital to the fight against human immunodeficiency virus (HIV) infection."

CNICS lets members combine secured data to track diagnosis and treatment outcomes, monitor hard-to-gather information like quality of life measurements and accurate medical histories, and links these data to a repository of clinical specimens.

CNICS serves as a one-of-a-kind research backbone for clinical, translational and basic science to address how HIV causes AIDS, HIV prevention and treatment advances.

"This type of network is the future of HIV/AIDS clinical research, and it serves as a model for clinical outcomes research and treatment monitoring for many other diseases," Saag said. It started two years ago with funding from UAB and the National Institutes of Health.

The other consortium members are Case Western Reserve University in Cleveland; Harvard University in Boston; Johns Hopkins University in Baltimore; the University of California, San Diego; the University of California, San Francisco and the University of Washington in Seattle. More research sites are expected to be added in the future. Information is available at www.cnics.net.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose